Application of SPECT to the in vivo measurement of benzodiazepine potency

Development of technetium-99m-based CNS receptor ligands: have there been any advances?

B Johannsen, HJ Pietzsch - European journal of nuclear medicine and …, 2002 - Springer
By virtue of its ideal nuclear physical characteristics for routine nuclear medicine diagnostics
and its ready availability, technetium-99m is of outstanding interest in the development of …
Save Cite Cited by 99 Related articles All 13 versions
[PDF] snmjournals.org

[PDF][PDF] Characterizing an ectopic secreting carcinoid with indium-111-DTPA-D-Phe-pentetreotide

V Briganti, M Mannelli, G La Cava, A Peri… - Journal of Nuclear …, 1997 - Soc Nuclear Med
FiGURE2. TotalANAsextractedfromthe neoplastictissue orfrom a human
neuroblastomacellline (CHP404, whichoverexpressesSSR2) weresub jected to RT …
Save Cite Cited by 18 Related articles All 13 versions

Central benzodiazepine receptor imaging and quantitation with single photon emission computerised tomography: SPECT

CI Okocha, F Kapczinski, N Lassen… - Journal of …, 1995 - journals.sagepub.com
This review discusses the current use of single photon emission computerised tomography
(SPECT) for central benzodiazepine receptor imaging and quantitation. The general …
Save Cite Cited by 4 Related articles All 7 versions

SPECT-Darstellung der Benzodiazepinrezeptoren

P Bartenstein - Single-Photon-Emissions-Computertomographie …, 1995 - Springer
Zusammenfassung Das erste Benzodiazepin, Chlordiazepoxid, wurde 1957 von Leo H.
Sternbach entdeckt [1]. Die 1960 in die Therapie eingeführte Substanzklasse hat neben …
Save Cite Related articles